| Company Name: |
Tcichem, Inc. |
| Tel: |
13918644899 |
| Email: |
81587635@qq.com |
4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester manufacturers
- TA-1801
-
- $2500.00
-
2026-04-21
- CAS:88352-44-7
- Purity:
- Supply Ability: 10g
- TA-1801
-
- $2500.00
-
2025-07-27
- CAS:88352-44-7
- Purity:
- Supply Ability: 10g
|
| | 4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester Basic information |
| | 4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester Chemical Properties |
| Melting point | 107-108 °C(Solv: ethanol (64-17-5)) | | Boiling point | 471.0±55.0 °C(Predicted) | | density | 1.275±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | -1.21±0.26(Predicted) |
| | 4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester Usage And Synthesis |
| Uses | TA-1801 is a hypolipidemic agent. | | in vivo | TA-1801 reduces serum cholesterol and triglyceride levels by 23% and 35%, respectively, at a dose of 0.05% in a diet in normal rats, and it is about 10 times more active in hereditary hyperlipidemic rats (THLR/1) than in normal rats[1]. | | References | [1] Moriya T, et al. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds. J Med Chem. 1988 Jun;31(6):1197-204. DOI:10.1021/jm00401a021 |
| | 4-Oxazoleacetic acid, 2-(4-chlorophenyl)-5-(2-furanyl)-, ethyl ester Preparation Products And Raw materials |
|